Abstract
Cirrhosis is a pathologic and clinical entity that occurs following repeated hepatocyte damage and is characterized by extensive fibrosis and innumerable regenerative nodules replacing the normal liver parenchyma. Ultimately, the process can lead to liver failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99:1160–74.
Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology. 2006;239:425–37.
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.
Baron RL, Peterson MS. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging – opportunities and pitfalls. Radiographics. 2001;21:S117–32.
Blachar A, Federle M, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology. 2001;220:329–36.
Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27–34.
Borzio M, Fargion S, Borzio F, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol. 2003;39:208–14.
Brancatelli G, Federle MP, Blachar A, Grazioli L. Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology. 2001;219:69–74.
Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics. 2002;22:847–62.
Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. Am J Roentgenol. 2003;180:1007–14.
Brancatelli G, Vilgrain V, Federle MP, et al. Budd-Chiari syndrome: spectrum of imaging findings. Am J Roentgenol. 2007;188:W168–76.
Bureau C, Péron JM, Sirach E, Selves J, Otal P, Vinel JP. Liver nodules resembling focal nodular hyperplasia after portal vein thrombosis. J Hepatol. 2004;41:499–500.
Choi BI, Han JK, Hong SH, et al. Dysplastic nodules of the liver: imaging findings. Abdom Imaging. 1999;24:250–7.
Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA. 2003;289:3000–4.
Di Lelio A, Cestani C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology. 1989;172:389–92.
Dodd GD, Baron RL, Oliver JH, Federle MP. End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology. 1999;211:357–62.
Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29:1615–35.
Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006;26:1621–36.
Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008;28:747–69.
Harbin WP, Robert NJ, Ferrucci JJ. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273–83.
Hussain HK, Syed I, Nghiem HV, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology. 2004;230:637–44.
International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983–93.
Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–9.
Ito K, Mitchell DG. Imaging diagnosis of cirrhosis and chronic hepatitis. Intervirology. 2004;47:134–43.
Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. Am J Roentgenol. 2002;178:1327–34.
Kim TK, Lee KH, Jang HJ, et al. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1–2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology. 2011;259:730–8.
Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging – a case report. Radiology. 1998;209:461–4.
Krinsky GA, Lee VS, Nguyen MT, et al. Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr. 2000;24:773–6.
Mitchell DG. MR imaging of cirrhosis and its complications. Abdom Imaging. 2000;25:455.
Murakami T, Baron RL, Peterson MS. Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. Radiology. 1996;198:239–42.
Ohtomo K, Baron RL, Dodd 3rd GD, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology. 1993;188:31–5.
Sagoh T, Itoh K, Togashi K, et al. Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology. 1989;172:685–7.
Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. Am J Roentgenol. 1994;163:1384–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Marin, D., Nelson, R. (2013). Cirrhosis. In: Hamm, B., Ros, P.R. (eds) Abdominal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13327-5_78
Download citation
DOI: https://doi.org/10.1007/978-3-642-13327-5_78
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13326-8
Online ISBN: 978-3-642-13327-5
eBook Packages: MedicineReference Module Medicine